Trial
NCT02817906
ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Intra-Cellular Therapies, Inc.
Collaborators
—
Condition
Agitation in Dementia, Including Alzheimer's Disease
Intervention
ITI-007
Why stopped
Pre-specified Interim Analysis Indicated Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-29